Internal medicine

QT Imaging’s Breast Acoustic CT™ Scanner to be Offered at The Center for New Medicine to Advance Personalized Prevention and Detection of Breast Cancer

Retrieved on: 
Thursday, April 11, 2024
Oncology, Medical Devices, Health, Consumer, Women, Biotechnology, FDA, Radiation, Woman, Internal medicine, Breast, Partnership, Research, 3D, Patient, Medicine, Medical director, Breast cancer, Medical imaging

The Center for New Medicine is one of the largest integrative medical clinics in North America, providing a personalized approach to health care including cancer prevention, its early detection, and internal medicine.

Key Points: 
  • The Center for New Medicine is one of the largest integrative medical clinics in North America, providing a personalized approach to health care including cancer prevention, its early detection, and internal medicine.
  • With the incorporation of the QT Imaging Breast Acoustic CT™ Scanner, the Center for New Medicine will expand their innovative services in women’s and breast health.
  • There is tremendous opportunity for new technology to advance women’s health, especially in breast cancer detection and treatment.
  • QT Imaging Breast Acoustic CT™ Scanner is the only 3D imaging device to receive FDA clearance for use as a transmission and reflection low frequency soundwaves imaging system for a patient’s breast.

AMBOSS Acquires NEJM Knowledge+ from NEJM Group, Setting a New Standard in Medical Education and Clinical Practice

Retrieved on: 
Thursday, April 25, 2024
Learning, Health care, Entrepreneurship, Acquisition, Physician, NEJM, Evidence-based medicine, Pediatrics, Health, Internal medicine, Student, Family medicine, Nursing

AMBOSS is renowned for its expert medical library, intuitive learning platform, and user interface designed to easily obtain and retain medical knowledge.

Key Points: 
  • AMBOSS is renowned for its expert medical library, intuitive learning platform, and user interface designed to easily obtain and retain medical knowledge.
  • "We are really excited to bring NEJM Knowledge+ into the AMBOSS family," said Dr. Madjid Salimi, Co-Founder and Co-CEO of AMBOSS.
  • "NEJM Group has always been at the forefront of disseminating medical knowledge and improving patient care," said David Sampson, Vice President, Chief Publishing Officer of NEJM Group.
  • Through this acquisition, AMBOSS and NEJM Group reaffirm their commitment to enhancing medical education and clinical practice.

Seed Health Appoints Microbiome Pioneer Zain Kassam, M.D., M.P.H., as Chief Medical Officer

Retrieved on: 
Wednesday, April 24, 2024
Western University, Harvard University, Nature Biotechnology, Public health, Chairperson, Abstract, Health, McMaster University, OpenBiome, FMT, Janssen, IPO, Therapy, Science, Ecology, Alumni, Internal medicine, Bacillota, Longevity, Growth, MIT, Medical device

BOSTON, April 24, 2024 /PRNewswire/ -- Seed Health, a microbiome science company, today announced the appointment of Zain Kassam, M.D., M.P.H., as Chief Medical Officer. An award-winning physician-scientist, Dr. Kassam has played a pivotal role in the advancement of microbiome science for over a decade. His extensive body of work includes over 200 peer-reviewed publications and abstracts, including in The New England Journal of Medicine, Nature Biotechnology, and Gastroenterology, and co-authoring international clinical practice guidelines. He has championed more than 30 Phase I-III clinical trials with top-tier academic institutions across multiple therapeutic areas. As Chief Medical Officer, Dr. Kassam will collaborate with Chief Scientific Officer, Dirk Gevers, Ph.D., to oversee Seed Health's R&D portfolio. He will expand the company's gut microbiome program and guide upcoming launches in the vaginal and skin microbiome sectors, as well as in brain health, metabolic health, and longevity.

Key Points: 
  • Dr. Kassam will lead Seed Health's clinical research and medical affairs, driving the
    BOSTON, April 24, 2024 /PRNewswire/ -- Seed Health , a microbiome science company, today announced the appointment of Zain Kassam, M.D., M.P.H., as Chief Medical Officer.
  • As Chief Medical Officer, Dr. Kassam will collaborate with Chief Scientific Officer, Dirk Gevers, Ph.D., to oversee Seed Health's R&D portfolio.
  • He will expand the company's gut microbiome program and guide upcoming launches in the vaginal and skin microbiome sectors, as well as in brain health, metabolic health, and longevity.
  • Before joining Seed Health, Dr. Kassam co-founded and was Chief Medical Officer at two foundational microbiome therapeutics companies, OpenBiome and Finch Therapeutics.

Dr. Anthony Fletcher Installed as President of the Association of Black Cardiologists

Retrieved on: 
Tuesday, April 23, 2024
Education, Xavier University, George Washington University Hospital, University, Blood, ABC, University of Cincinnati, Heart, Capacity building, Chairperson, Doctor of Philosophy, FACC, Cardiology, Cardiovascular disease, MBA, Internal medicine, ABC Board

WASHINGTON, April 23, 2024 /PRNewswire/ -- The Association of Black Cardiologists (ABC) proudly announces it 20th President, Dr. Anthony Fletcher.

Key Points: 
  • WASHINGTON, April 23, 2024 /PRNewswire/ -- The Association of Black Cardiologists (ABC) proudly announces it 20th President, Dr. Anthony Fletcher.
  • He is an interventional cardiologist with CHI St. Vincent Cardiology and Medicine Clinic in Little Rock, Arkansas.
  • Dr. Fletcher is a graduate of Xavier University in Cincinnati, Ohio, and the University of Cincinnati College of Medicine.
  • During his presidency, Dr. Fletcher is committed to forging the mission and vison of the ABC by ensuring inclusivity and diversity for all.

Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer

Retrieved on: 
Tuesday, April 23, 2024
Third Rock Ventures, Factorization of polynomials, University, Cancer, Flare, Immunology, Biostatistics, Hospital, Pharmacovigilance, ACRS, Arena, GSK plc, Cardiology, Head, Virology, Pharmacy, Science, Bristol Myers Squibb, Neurology, Acquisition, DSM-IV codes, Public key certificate, Fibrosis, Arena Pharmaceuticals, Harvard Medical School, Pfizer, BMS, Internal medicine, FRCP, Drug development, Therapy, Massachusetts General Hospital, Biotechnology, Growth, Pharmaceutical industry

CAMBRIDGE, Mass., April 23, 2024 /PRNewswire/ -- Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced the appointment of Douglas Manion, M.D., FRCP (C), as Chief Executive Officer, effective immediately.

Key Points: 
  • CAMBRIDGE, Mass., April 23, 2024 /PRNewswire/ -- Flare Therapeutics Inc., a clinical-stage biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases, today announced the appointment of Douglas Manion, M.D., FRCP (C), as Chief Executive Officer, effective immediately.
  • Dr. Manion brings over two decades of experience in pharmaceutical research and development, having held leadership roles across several biotechnology and pharmaceutical companies.
  • He succeeds interim CEO Abbie Celniker, Ph.D., a partner at Third Rock Ventures, who will continue to serve as Chair of the Company's Board of Directors.
  • Dr. Manion joins Flare Therapeutics from Aclaris Therapeutics, Inc. (NASDAQ: ACRS), where he was President and Chief Executive Officer.

TGH North Announces TGH Brooksville and TGH Spring Hill Board of Managers

Retrieved on: 
Monday, April 22, 2024
Rollins College, Tampa General Hospital, Teaching, Partnership, Business, Culture, Charity Hospital, Damascus University, Emergency medicine, Council, Love, Emergency, Executive Committee, Harvard University, Safety, Hospital, Research, TGH, Family, Bank, Foreign policy, Sale, Damascus Hospital, University, Gastroenterology, Internal medicine, University School, History, Acquisition, Physician, Management

BROOKSVILLE, Fla., April 22, 2024 /PRNewswire/ -- TGH North, a division of Tampa General Hospital, announced its new TGH Brooksville and TGH Spring Hill board of managers, which will serve as a guide for leadership and oversee operations. The board convened Wednesday in Brooksville for its inaugural meeting.

Key Points: 
  • BROOKSVILLE, Fla., April 22, 2024 /PRNewswire/ -- TGH North , a division of Tampa General Hospital, announced its new TGH Brooksville and TGH Spring Hill board of managers, which will serve as a guide for leadership and oversee operations.
  • M. Rodwan Hiba, M.D., has been a member of the medical staff at TGH Brooksville and TGH Spring Hill since 1999.
  • The board of managers at TGH North serves as the governing body for the operations in Hernando County.
  • TGH North was formed on December 1, 2023, when Tampa General completed the acquisition of the Bravera Health network.

University of Medicine and Health Sciences Celebrates Historic Match Day for Graduating Students

Retrieved on: 
Monday, April 22, 2024
Blog, University, Spectrum Health, Learning, Psychiatry, Emergency medicine, Dream, Anesthesiology, Internal medicine, Pediatrics, Pathology, History, UMHS, Obstetrics, Patient, Neurology, Child, Rehabilitation, Student, Detroit Medical Center, General surgery, Case Western Reserve University, COVID-19, Interventional radiology, Nursing

NEW YORK, April 22, 2024 /PRNewswire-PRWeb/ -- The University of Medicine and Health Sciences, (UMHS), a small, mission-driven medical school with a commitment to student support and a legacy of successful residency placements in the United States and Canada, celebrated one of its most successful Match Days in history. A remarkable 91% of first-time applicants secured residency placements, with graduating students earning positions in competitive programs across 14 medical specialties spanning 27 states, Puerto Rico, and Canada.

Key Points: 
  • In a message to students, UMHS President Warren Ross praised the school's historic 2024 Match results.
  • Graduating students secured residencies in highly competitive programs and will continue their training at esteemed teaching hospitals such as Case Western in Ohio and the University of Massachusetts Chan Medical School.
  • UMHS students matched into all six core specialties, including family medicine, internal medicine, obstetrics & gynecology, pediatrics, psychiatry, and surgery, as well as eight specialty fields, including anesthesiology, child neurology, diagnostic radiology, emergency medicine, neurology, pathology, and physical medicine and rehabilitation.
  • To learn more about the UMHS Class of 2024 Match Day and to see the complete 2024 Match results please visit https://www.umhs-sk.org/match-results .

American College of Physicians issues clinical recommendations for newer pharmacological treatments of adults with Type 2 diabetes

Retrieved on: 
Friday, April 19, 2024
ACP, Mortality, MACP, Stroke, Annals of Internal Medicine, American College, Meta-analysis, Risk, DPP-4, Guideline, Development, Assessment, Type 2 diabetes, Type 2, GRADE, Patient, Diabetes, Myocardial infarction, Weight loss, Internal medicine, Hospital, Chronic kidney disease, Metformin, Hypoglycemia, Heart, Systematic review, Disease

BOSTON, April 19, 2024 /PRNewswire/ -- The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes. The clinical guideline is based on the best available evidence for effectiveness, comparative benefits and harms, consideration of patients' values and preferences, and costs. Newer Pharmacological Treatments in Adults with Type 2 Diabetes: A Clinical Guideline from the American College of Physicians was published today in Annals of Internal Medicine.

Key Points: 
  • Reviews evidence of newer medications, recommends adding to metformin
    BOSTON, April 19, 2024 /PRNewswire/ -- The American College of Physicians (ACP) today released an update of its 2017 guideline with clinical recommendations for the use of newer pharmacological treatments of adults with Type 2 diabetes.
  • Newer Pharmacological Treatments in Adults with Type 2 Diabetes: A Clinical Guideline from the American College of Physicians was published today in Annals of Internal Medicine.
  • ACP today released clinical recommendations for the use of newer treatments in adults with Type 2 diabetes.
  • This clinical guideline is based on a systematic review of the effectiveness and harms of newer pharmacological treatments for Type 2 diabetes.

BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn

Retrieved on: 
Tuesday, April 16, 2024
FDA, CMO, Psychiatry, SPA, Internal medicine, Therapy, Science, GSK, Patient, Neurology, ALS, Medicine, Drug development, Medical Center, Pharmaceutical industry

NEW YORK, April 16, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced the promotion of Dr. Bob Dagher to Executive Vice President and Chief Medical Officer. In addition, after four years of maintaining top executive roles, Dr. Stacy Lindborg stepping down from the role of Co-CEO and will remain with BrainStorm as a member of its Board of Directors. These strategic management changes are being made as the Company prepares to embark on a registrational Phase 3b trial for NurOwn®, its investigational cell therapy treatment for amyotrophic lateral sclerosis (ALS).

Key Points: 
  • These strategic management changes are being made as the Company prepares to embark on a registrational Phase 3b trial for NurOwn®, its investigational cell therapy treatment for amyotrophic lateral sclerosis (ALS).
  • In his new role as Executive Vice President and Chief Medical Officer, Dr. Dagher's responsibilities will include overseeing the planned Phase 3b registration trial of NurOwn.
  • "Bob's capabilities, which include expertise in neurology, psychiatry, and rare diseases, make him exceptionally qualified as we launch the Phase 3b trial of NurOwn and prepare for success.
  • The opportunity to lead our talented clinical team through the upcoming Phase 3b trial is incredibly exciting.

The Inner Circle acknowledges Tanveer P. Mir, MD, MACP as a Pinnacle Lifetime Member

Retrieved on: 
Friday, April 12, 2024
Organization, Administration, MACP, American College, Palliative care, MBBS, Hospice, Gardening, Health, Internal medicine, Geriatrics, Mentorship, GLEN, Parent, North Shore University Hospital, Bachelor, Patient, Teaching hospital, Multimedia, Nassau University Medical Center, Inner circle, Knowledge, Nursing

GLEN COVE, N.Y., April 12, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Tanveer P. Mir, MD, MACP is acknowledged as a Pinnacle Lifetime Member for her contributions as a Respected Leader in Medicine and Administration.

Key Points: 
  • GLEN COVE, N.Y., April 12, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Tanveer P. Mir, MD, MACP is acknowledged as a Pinnacle Lifetime Member for her contributions as a Respected Leader in Medicine and Administration.
  • Her dedication to patient care and her leadership in healthcare institutions have solidified her reputation as a respected figure in the industry.
  • Currently serving as the Chairperson at NYC Health + Hospitals/South Brooklyn Health, Ruth Bader Ginsburg Hospital, Dr. Mir oversees various administrative functions of the facility.
  • She is deeply committed to providing the highest quality of care to the elderly population, addressing their unique healthcare needs.